Cart
sales@molnova.com
Adrenomedullin (16-31), human
CAS No. 318480-38-5
Adrenomedullin (16-31), human( —— )
Catalog No. M30185 CAS No. 318480-38-5
Adrenomedullin (16-31), human is amino acid residues 16-31 fragment of human adrenomedullin (hADM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAdrenomedullin (16-31), human
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdrenomedullin (16-31), human is amino acid residues 16-31 fragment of human adrenomedullin (hADM).
-
DescriptionAdrenomedullin (16-31), human is amino acid residues 16-31 fragment of human adrenomedullin (hADM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number318480-38-5
-
Formula Weight1865.19
-
Molecular FormulaC82H129N25O21S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (53.61 mM)
-
SMILES——
-
Chemical NameSequence:{Cys}{Arg}{Phe}{Gly}{Thr}{Cys}{Thr}{Val}{Gln}{Lys}{Leu}{Ala}{His}{Gln}{Ile}{Tyr}-NH2
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
R 892
Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively). Exhibits no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (ACE) cleavage. Displays hypertensive activity in vivo.
-
Crilvastatin
Crilvastatin (PMD 387) is a novel, non-competitive hydroxymethylglutaryl coenzyme A reductase inhibitor with cholesterol-lowering activity, inhibiting cholesterol uptake in rats with hereditary hypercholesterolemia.
-
(D-Arg2,Sar4)-Dermor...
(D-Arg2, Sar 4)-Dermorphin (1-4) is a tetrapeptide derivative of the peptide Dermorphin found in amphibian skin. (D-Arg2, Sar 4)-Dermorphin (1-4) has significant analgesic effects by binding to the μ-opioid receptor (MOR) in the body. (D-Arg2, Sar 4)-Dermorphin (1-4) can be used in the development of analgesic drugs.
